Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response ASR Q1 2026 Earnings EPS Misses Estimates by 153 Stock Declines ONTO Q1 2026 Earnings EPS Misses Estimates by 163 Amid Unreported Revenue Kadant Inc KAI Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty